logo BDSP

Base documentaire

  1. Communication regarding adverse drug reactions between secondary and primary care : a postal questionnaire survey of general practitioners.

    Article - En anglais

    GPs are not always informed that their patient suffered an adverse drug reaction (ADR) while in hospital.

    We have conducted a postal questionnaire survey of 270 GPs in order to elicit their views regarding provision of information from secondary care regarding ADRs.

    Of the 141 (52.2%) GPs that replied, 127 (90.1%) saw patients that had experienced an ADR in hospital.

    Of these GPs, 113 (89%) stated that they encountered instances where no record of the ADR existed in patients'discharge documentation.

    Where written information was absent, GPs are reliant on information given to them by patients.

    Of those responding, none were'very confident'of this information, while 92 (78.6%) were'uncertain'or'very uncertain'of this information.

    A sample notification form was developed.

    GPs were generally satisfied with its content and 110 (82.7%) thought that patients should receive a copy.

    Almost all GPs (135 (97.8%)) felt that it would be appropriate to provide patients with ADR warning cards.

    Ensuring that patients and their carers are aware of drugs to which they may be allergic or intolerant through verbal and written methods should minimize the unnecessary risks of inadvertent re-exposure.

    Mots-clés Pascal : Médecin généraliste, Communication information, Hôpital, Médicament, Effet secondaire, Toxicité, Malade, Enquête, Système information, Royaume Uni, Europe, Sortie hôpital, Personnel sanitaire, Dossier médical, Homme

    Mots-clés Pascal anglais : General practitioner, Information communication, Hospital, Drug, Secondary effect, Toxicity, Patient, Survey, Information system, United Kingdom, Europe, Hospital discharge, Health staff, Medical record, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0301544

    Code Inist : 002B30A05. Création : 16/11/1999.